Prosecution Insights
Prosecution Insights
Tech Center 1700 • Art Units: 1600 1612 1646 1774
This examiner grants 100% of resolved cases
Eric Parker Mosher is an examiner in Tech Center 1700 and Art Unit 1600. The data is based on 2 resolved cases. The allowance rate is 100.0 percent. The median days to allowance is 1106. These figures represent the current recorded history for this examiner and provide a starting point for applicant evaluation.
The interview lift is 0.0 percent. This figure indicates that interviews did not change the allowance rate in this very small sample compared to the 100.0 percent baseline. With only 2 resolved cases, practitioners should be cautious when interpreting these specific metrics to predict future outcomes in Art Unit 1600.
The 1106 day median is the primary indicator of the prosecution timeline based on the available data. While the 100.0 percent allowance rate is the current recorded value, more cases are needed to establish a broad statistical base. These metrics provide an initial baseline for understanding the examiner's performance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18829184 | Methods for In Vivo Tracking of Cells | Non-Final OA | Wisconsin Alumni Research Foundation |
| 18672926 | PROTEASE-RESPONSIVE SURFACE-POTENTIAL-TUNABLE PEPTIDE CONSTRUCTS FOR SELECTIVE IMAGING AND ACCURATE INHIBITOR SCREENING | Non-Final OA | The Regents of the University of California |
| 18320487 | METHOD AND DEVICE FOR PRODUCING A LIQUID CONTAINING LIPOSOMES, AND PRODUCED LIQUID | Non-Final OA | Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V. |
| 18219922 | RATIONAL DESIGN OF THREE-DIMENSIONAL BIODEGRADABLE CORE-UPCONVERSION TETRAGONAL NANODENDRITES WITH ULTRABRIGHT LUMINESCENCE FOR VARIOUS BIOMEDICAL APPLICATIONS | Final Rejection | RESEARCH & BUSINESS FOUNDATION SUNGKYUNKWAN UNIVERSITY |
| 18703086 | TARGETED RADIOTHERANOSTICS BASED ON POLYAZAMACROCYCLIC, MIXED-DONOR SCAFFOLDS LINKED TO A TARGETING VECTOR | Non-Final OA | The Research Foundation for the State University of New York |
| 18578888 | PORPHYRIN NANOVESICLE WITH FATTY ACID CONJUGATE | Non-Final OA | UNIVERSITY HEALTH NETWORK |
| 18919564 | USE OF MULTIPHOTON EXCITATION FOR FLUORESCENCE IMAGING OF STAINED CALCIFIED MINERALS | Non-Final OA | UNIVERSITY OF MARYLAND, BALTIMORE |
| 18925158 | Perfluorocarbon-Containing Contrast Agent for Use in MRI Imaging of Body Cavities | Non-Final OA | University of Pittsburgh - Of the Commonwealth System of Higher Education |
| 18451174 | BIODEGRADABLE RADIOPAQUE MICROSPHERE | Final Rejection | Varian Medical Systems, Inc. |
| 18575098 | RADIOLABELED PARP INHIBITOR CONJUGATES FOR CANCER TREATMENT | Non-Final OA | DUKE UNIVERSITY |
| 18495141 | HYDROPORPHYRIN-DOPED NEAR-INFRARED-EMITTING POLYMER DOTS FOR CELLULAR FLUORESCENCE IMAGING | Final Rejection | UNIVERSITY OF MARYLAND, BALTIMORE COUNTY |
| 17596831 | CONJUGATES OF pi-ELECTRON-PAIR-DONATING HETEROAROMATIC NITROGEN-COMPRISING COMPOUNDS | Final Rejection | Ascendis Pharma A/S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy